FDA clears Chromogenix APC test
This article was originally published in Clinica
Executive Summary
The FDA has cleared Chromogenix' APC resistance test, Coatest, for sale in the US. APC resistance, an inability to shut down coagulation, is inherited in nine out of 10 cases and is also associated with ageing. The Molndal, Sweden-based company has been selling the test in Europe since 1993 where it is one of the company's main products. Chromogenix was granted a US patent for the test technique in August.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 9 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.